Literature DB >> 22471982

Transthyretin deposition in familial amyloidotic polyneuropathy.

M J Saraiva1, J Magalhaes, N Ferreira, M R Almeida.   

Abstract

The subject of the review is on hereditary transthyretin (TTR) amyloidosis which is a genetically transmitted disease that results from a mutation in the gene encoding the plasma TTR protein. TTR is a transport protein for thyroid hormones and vitamin A and is predominantly synthesised in the liver. Although originally regarded as a rare disease, it is now becoming clear that many kindreds exist worldwide. Current knowledge and hypotheses on the biology of TTR, mechanisms of TTR amyloid fibril formation, phenotypic consequences TTR amyloid deposition and pre-clinical models of the disease will be discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22471982     DOI: 10.2174/092986712800269236

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  23 in total

1.  Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Authors:  Peter J Dyck; John C Kincaid; P James B Dyck; Vinay Chaudhry; Namita A Goyal; Christina Alves; Hayet Salhi; Janice F Wiesman; Celine Labeyrie; Jessica Robinson-Papp; Márcio Cardoso; Matilde Laura; Katherine Ruzhansky; Andrea Cortese; Thomas H Brannagan; Julie Khoury; Sami Khella; Márcia Waddington-Cruz; João Ferreira; Annabel K Wang; Marcus V Pinto; Samar S Ayache; Merrill D Benson; John L Berk; Teresa Coelho; Michael Polydefkis; Peter Gorevic; David H Adams; Violaine Plante-Bordeneuve; Carol Whelan; Giampaolo Merlini; Stephen Heitner; Brian M Drachman; Isabel Conceição; Christopher J Klein; Morie A Gertz; Elizabeth J Ackermann; Steven G Hughes; Michelle L Mauermann; Rito Bergemann; Karen A Lodermeier; Jenny L Davies; Rickey E Carter; William J Litchy
Journal:  Muscle Nerve       Date:  2017-04-07       Impact factor: 3.217

2.  Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history study.

Authors:  David Adams; Teresa Coelho; Laura Obici; Giampaolo Merlini; Zoia Mincheva; Narupat Suanprasert; Brian R Bettencourt; Jared A Gollob; Pritesh J Gandhi; William J Litchy; Peter J Dyck
Journal:  Neurology       Date:  2015-07-24       Impact factor: 9.910

Review 3.  The role of transthyretin in cell biology: impact on human pathophysiology.

Authors:  Joana Magalhães; Márcia Almeida Liz; Jessica Eira
Journal:  Cell Mol Life Sci       Date:  2021-07-23       Impact factor: 9.261

4.  The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.

Authors:  João Moreira; Susete Costelha; Margarida Saraiva; Maria João Saraiva
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

5.  Inhibition of human transthyretin aggregation by non-steroidal anti-inflammatory compounds: a structural and thermodynamic analysis.

Authors:  Ricardo O Sant'anna; Carolina A Braga; Igor Polikarpov; Salvador Ventura; Luis Mauricio T R Lima; Debora Foguel
Journal:  Int J Mol Sci       Date:  2013-03-06       Impact factor: 5.923

Review 6.  Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure.

Authors:  Traci L Parry; Jason H Melehani; Mark J Ranek; Monte S Willis
Journal:  Front Cardiovasc Med       Date:  2015-05-19

7.  Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.

Authors:  Anabela C Teixeira; Maria J Saraiva
Journal:  J Cell Mol Med       Date:  2013-02-07       Impact factor: 5.310

8.  Amyloid-beta neuroprotection mediated by a targeted antioxidant.

Authors:  Courtney R Giordano; Laura J Terlecky; Aliccia Bollig-Fischer; Paul A Walton; Stanley R Terlecky
Journal:  Sci Rep       Date:  2014-05-15       Impact factor: 4.379

9.  The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses.

Authors:  Ricardo Sant'Anna; Carolina Braga; Nathalia Varejão; Karinne M Pimenta; Ricardo Graña-Montes; Aline Alves; Juliana Cortines; Yraima Cordeiro; Salvador Ventura; Debora Foguel
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

10.  Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin Tetramer.

Authors:  Irina Iakovleva; Afshan Begum; Kristoffer Brännström; Alexandra Wijsekera; Lina Nilsson; Jin Zhang; Patrik L Andersson; A Elisabeth Sauer-Eriksson; Anders Olofsson
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.